BioPharma Credit Plc
(OTC) BOPCF
BioPharma Credit Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$264.69M
Net Income (TTM)
$252.06M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.05
Beta (Volatility)
0.07 (Low)
Dividend
$0.05
Beta (Volatility)
0.07 (Low)
Price
$0.95
Volume
1
Open
$0.96
Price
$0.95
Volume
1
Open
$0.96
Previous Close
$0.95
Daily Range
$0.95 - $0.96
52-Week Range
$0.76 - $1.00
Dividend
$0.05
Beta (Volatility)
0.07 (Low)
Price
$0.95
Volume
1
Open
$0.96
Previous Close
$0.95
Daily Range
$0.95 - $0.96
52-Week Range
$0.76 - $1.00
BOPCF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioPharma Credit Plc
BOPCF Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
93%
Net Income Margin
93%
Return on Equity
0%
Return on Capital
11%
Return on Assets
11%
Earnings Yield
N/A
Dividend Yield
0.05%
Payout Ratio
84.98%
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
1
Short Interest
0.00%
Avg. Volume
93.20K
Financials (TTM)
Gross Profit
$114.50M
Operating Income
$129.85M
EBITDA
$129.89M
Operating Cash Flow
$91.09M
Capital Expenditure
$0.00
Free Cash Flow
$91.09M
Cash & ST Invst.
$12.59M
Total Debt
$0.00
BioPharma Credit Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$63.08M
+10.2%
Gross Profit
$47.36M
-17.2%
Gross Margin
75.07%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
0
N/A
Net Income
$57.10M
+52.2%
EBITDA
$57.10M
+815871.4%
Quarterly Fundamentals
Net Cash
$12.59M
-90.7%
Accounts Receivable
$53.60M
+165.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
11.12%
N/A
Return on Invested Capital
11.24%
N/A
Free Cash Flow
$57.34M
-38.2%
Operating Cash Flow
$57.34M
-38.2%